JNJ

Stryker, J&J and Abbott ranked as top companies to work at in the U.S.
Stryker, J&J and Abbott ranked as top companies to work at in the U.S.
Medical Devices and Diagnostics Industry
devices
Stryker
JNJ
Abbott Labs
Flag link:
A Huge Decision Is on Tap for This Little Biotech Stock
A Huge Decision Is on Tap for This Little Biotech Stock
Yahoo/Motley Fool
Geron
JNJ
imetelstat
myelofibrosis
Flag link:
DePuy Synthes touts improved functionality, shorter hospital stays with Attune knee
DePuy Synthes touts improved functionality, shorter hospital stays with Attune knee
Mass Device
JNJ
DePuy Synthes
Attune knee
knee implants
devices
Flag link:
J&J’s DePuy Synthes acquires Medical Enterprises Distribution assets
J&J’s DePuy Synthes acquires Medical Enterprises Distribution assets
Mass Device
JNJ
DePuy Synthes
Medical Enterprises Distribution
ME1000
M&A
Flag link:
Janssen obtains FDA approval for Darzalex (multiple myeloma)
Janssen obtains FDA approval for Darzalex (multiple myeloma)
GoinPharma
Janssen
JNJ
Darzalex
Takeda
Velcade
Multiple Myeloma
FDA
Flag link:
Johnson & Johnson unveils new Asia-Pacific headquarters in Singapore
Johnson & Johnson unveils new Asia-Pacific headquarters in Singapore
HRM Asia
JNJ
Singapore
Flag link:
J&J’s Janssen touts Ph3 data for antidepressant nasal spray
J&J’s Janssen touts Ph3 data for antidepressant nasal spray
Drug Delivery Business News
JNJ
Janssen
esketamine
depression
Flag link:
With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine
With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine
Endpoints
JNJ
esketamine
major depression
Flag link:
J&J’s Janssen acquires cancer-killing virus tech
J&J’s Janssen acquires cancer-killing virus tech
Drug Delivery Business News
JNJ
Janssen
BeneVir
oncolytic viruses
Flag link:
Report: Johnson & Johnson wins appeal in $151m hip verdict
Report: Johnson & Johnson wins appeal in $151m hip verdict
Mass Device
JNJ
devices
Pinnacle Hip
hip implants
Flag link:
Report: Johnson & Johnson sees Vision Care biz grow, looks to expand beyond contacts
Report: Johnson & Johnson sees Vision Care biz grow, looks to expand beyond contacts
Mass Device
JNJ
eye health
Flag link:
Johnson & Johnson Develops First Light-Adaptive Contact Lenses
Johnson & Johnson Develops First Light-Adaptive Contact Lenses
Xtalks
JNJ Vision
JNJ
Transitions Optical
Acuvue Oasys
contact lenses
Flag link:
3 Drugs That Are Moving the Needle at Johnson & Johnson
3 Drugs That Are Moving the Needle at Johnson & Johnson
Motley Fool
JNJ
Darzalex
Zytiga
Stelara
earnings
Flag link:
J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout
J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout
Endpoints
JNJ
Actelion
antibiotics
C. difficile
cadazolid
Flag link:
Johnson & Johnson tops 1Q views on sales spike, but net dips
Johnson & Johnson tops 1Q views on sales spike, but net dips
Yahoo/AP
JNJ
earnings
Flag link:
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
CP Wire
JNJ
esketamine
depression
major depression
Flag link:
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
JNJ
esketamine
depression
major depression
Flag link:
Johnson & Johnson (JNJ) Expected to Announce Quarterly Sales of $19.38 Billion
Johnson & Johnson (JNJ) Expected to Announce Quarterly Sales of $19.38 Billion
Daily Political
JNJ
earnings
Flag link:
Q1 kicks off with J&J, Novartis, Glaxo results
Q1 kicks off with J&J, Novartis, Glaxo results
Biopharma Dive
earnings
JNJ
Novartis
GSK
Flag link:
Can Johnson & Johnson Get Its Mojo Back?
Can Johnson & Johnson Get Its Mojo Back?
Motley Fool
JNJ
Flag link:

Pages